2024

Publication 2024


420.

Frattini T, Devos H, Makridakis M, Roubelakis MG, Latosinka A, Mischak H, Schanstra JP, Vlahou A, Saulnier-Blache JS.

Benefits and limits of decellularization on mass-spectrometry-based extracellular matrix proteome analysis of mouse kidney

Proteomics. 2024, Jun 19:e2400052. Epub ahead of print


View Abstract      Request Reprint

 

419.

Heidegger I, Frantzi M, Salcher S, Tymoszuk P, Martowicz A, Gomez-Gomez E, Blanca A, Lendinez Cano G, Latosinska A, Mischak H, Vlahou A, Langer C, Aigner F, Puhr M, Krogsdam A, Trajanoski Z, Wolf D, Pircher A.

Prediction of Clinically Significant Prostate Cancer by a Specific Collagen-related Transcriptome, Proteome, and Urinome Signature

Eur Urol Oncol. 2024, Jun 7:S2588-9311(24)00144-5. Epub ahead of print


View Abstract      Request Reprint

 

418.

Latosinska A, Siwy J, Mischak H.

Multiomics: paving the path towards personalized prevention of hypertension

J Hypertens. 2024, 42(6):962-964. Epub 2024 May 1.


View Abstract      Request Reprint

 

417.

Yu YL, Siwy J, An DW, González A, Hansen T, Latosinska A, Pellicori P, Ravassa S, Mariottoni B, Verdonschot JA, Ahmed F, Petutschnigg J, Rossignol P, Heymans S, Cuthbert JJ, Girerd N, Clark AL, Verhamme P, Nawrot TS, Janssens S, Cleland JG, Zannad F, Diez J, Mischak H, Ferreira JP, Staessen JA; HOMAGE investigators.

Urinary proteomic signature of mineralocorticoid receptor antagonism by spironolactone: evidence from the HOMAGE trial

Heart. 2024, May 9:heartjnl-2023-323796. Epub ahead of print


View Abstract      Request Reprint


416.

Lauder L, Siwy J, Mavrogeorgis E, Keller F, Kunz M, Wachter A, Emrich IE, Böhm M, Mischak H, Mahfoud F.

Impact of Renal Denervation on Urinary Peptide-Based Biomarkers in Hypertension

Hypertension. 2024, 81(6):1374-1382. Epub 2024 Apr 4.


View Abstract      Request Reprint


415.

Mavrogeorgis E, Kondyli M, Mischak H, Vlahou A, Siwy J, Rossing P, Campbell A, Mels CMC, Delles C, Staessen JA, Latosinska A, Persu A.

Multiple urinary peptides are associated with hypertension: a link to molecular pathophysiology

J Hypertens. 2024, 42(8):1331-1339. Epub 2024 Mar 28.


View Abstract      Request Reprint

 

414.

Faguer S, Piedrafita A, Sanz AB, Siwy J, Mina IK, Alves M, Bousquet P, Marcheix B, Casemayou A, Klein J, Minville V, Breuil B, Ortiz A, Schanstra JP.

Performances of acute kidney injury biomarkers vary according to sex

Clin Kidney J. 2024, 17(5):sfae091.


View Abstract      Request Reprint

 

413.

Lumi R, Petri S, Siwy J, Latosinska A, Raad J, Zürbig P, Skripuletz T, Mischak H, Beige J.

Small peptide CSF fingerprint of amyotrophic lateral sclerosis

PLoS One. 2024, 19(4):e0302280.


View Abstract      Request Reprint

 

412.

Jaimes Campos MA, Mavrogeorgis E, Latosinska A, Eder S, Buchwinkler L, Mischak H, Siwy J, Rossing P, Mayer G, Jankowski J.

Urinary peptide analysis to predict the response to blood pressure medication

Nephrol Dial Transplant. 2024, 39(5):873-883. Epub 2023 Oct 31.


View Abstract     Request Reprint


411.

Mavrogeorgis E, Valkenburg S, Siwy J, Latosinska A, Glorieux G, Mischak H, Jankowski J.

Integration of Urinary Peptidome and Fecal Microbiome to Explore Patient Clustering in Chronic Kidney Disease

Proteomes 2024, 12(2):11.


View Abstract      Request Reprint

 

410.

Rupprecht H, Catanese L, Amann K, Hengel FE, Huber TB, Latosinska A, Lindenmeyer MT, Mischak H, Siwy J, Wendt R, Beige J.

Assessment and Risk Prediction of Chronic Kidney Disease and Kidney Fibrosis Using Non-Invasive Biomarkers

Int J Mol Sci. 2024, 25(7):3678.


View Abstract     Request Reprint


409.

Catanese L, Rupprecht H, Huber TB, Lindenmeyer MT, Hengel FE, Amann K, Wendt R, Siwy J, Mischak H, Beige J.

Non-Invasive Biomarkers for Diagnosis, Risk Prediction, and Therapy Guidance of Glomerular Kidney Diseases: A Comprehensive Review

Int J Mol Sci. 2024, 25(6):3519.


View Abstract     Request Reprint


408.

Mina IK, Mavrogeorgis E, Siwy J, Stojanov R, Mischak H, Latosinska A, Jankowski V.

Multiple urinary peptides display distinct sex-specific distribution

Proteomics. 2024 Mar;24(5):e2300227. Epub 2023 Sep 26.


View Abstract     Request Reprint


407.

Mavrogeorgis E, He T, Mischak H, Latosinska A, Vlahou A, Schanstra JP, Catanese L, Amann K, Huber TB, Beige J, Rupprecht H, Siwy J.

Urinary peptidomic liquid biopsy for non-invasive differential diagnosis of chronic kidney disease

Nephrol Dial Transplant. 2024, 39(3):453-462. Epub 2023 Sep 11.


View Abstract     Request Reprint

 

406.

Yu YL, Huang QF, An DW, Raad J, Martens DS, Latosinska A, Stolarz-Skrzypek K, Van Cleemput J, Feng YQ, Mischak H, Allegaert K, Verhamme P, Janssens S, Nawrot TS, Staessen JA.

OSTEO18, a novel urinary proteomic signature, associated with osteoporosis in heart transplant recipients

Heliyon. 2024, 10(2):e24867.


View Abstract     Request Reprint

 

405.

Brasseler M, Mischak H, Schanstra JP, Michel JM, Pape L, Felderhoff-Müser U.

Gestational Age-Related Urinary Peptidome Changes in Preterm and Term Born Infants

Neonatology. 2024, 121(3):305-313. Epub 2024 Feb 21.


View Abstract     Request Reprint

Share by: